Vicore Pharma Holding AB earnings
Annual earnings per share (SEK per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2023 | 2023-12-31 | SEK -3.22 | SEK -3.22 | 2026-06-19T06:16:06Z |
| 2022 | 2022-12-31 | SEK -3.99 | SEK -3.99 | 2026-06-19T06:16:06Z |
Revenue & profit (SEK)
| Concept | 2023 | 2022 |
|---|---|---|
| Revenue | SEK 0 | SEK 0 |
| Profit for the year | -SEK 310.9M | -SEK 288.4M |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in Vicore Pharma Holding AB's ESEF annual reports (source:
filings.xbrl.org).
Figures are in SEK, as reported. Not investment advice.